Familial liability to schizophrenia and mood disorders and cognitive impairment in psychosis

Psychiatry Research

Volumn 227, Issue 2-3, 2015, Pages 258-264

  Cuesta, Manuel J ^a,b   Zarzuela, Amalia ^a,b   Sánchez Torres, Ana M ^a,b,e   Lorente Omeñaca, Ruth ^a,b,e   Moreno Izco, Lucía ^a,b   Sanjuán, Julio ^c,d   Peralta, Victor ^a,b  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b IdiSNA Navarra Institute for Health Research   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Instituto Universitario IVI INCLIVA   (Spain)

^e UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Bipolar disorder; Cognitive functioning; Psychosis; Relatives; Schizophrenia

Indexed keywords

BIPERIDEN;

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXECUTIVE FUNCTION; FAMILIAL LIABILITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PATIENT; MOOD DISORDER; PATIENT CODING; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; VISUAL MEMORY; COMPLICATION; GENETICS; SEVERITY OF ILLNESS INDEX; STATISTICAL ANALYSIS;

ADULT; ATTENTION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MEMORY; MOOD DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 84929130808     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.03.024     Document Type: Article

References (58)

1. Aberg K., Adkins D.E., Liu Y., McClay J.L., Bukszar J., Jia P., Zhao Z., Perkins D., Stroup T.S., Lieberman J.A., Sullivan P.F., van den Oord E.J. Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics Journal 2012, 12(2):165-172.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms 1984, University of Iowa, Iowa.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms 1984, University of Iowa, Iowa.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington.
5. Anglin D., Stanford A.D., Harkavy-Friedman J.M., Goetz R., Rosenfield P., Malaspina D. Family history of affective illness in schizophrenia patients: symptoms and cognition. Schizophrenia Research 2009, 110(1-3):24-27.
6. Barch D.M., Ceaser A. Cognition in schizophrenia: core psychological and neural mechanisms. Trends in Cognitive Sciences 2012, 16(1):27-34.
7. Baron I.S., Rey-Casserly C. Extremely preterm birth outcome: a review of four decades of cognitive research. Neuropsychology Review 2010, 20(4):430-452.
8. Bora E., Yücel M., Pantelis C. Neurocognitive markers of psychosis in bipolar disorder: a meta-analytic study. Journal of Affective Disorders 2010, 127(1-3):1-9.
9. Bourne C., Aydemir O., Balanza-Martinez V., Bora E., Brissos S., Cavanagh J.T., Clark L., Cubukcuoglu Z., Dias V.V., Dittmann S., Ferrier I.N., Fleck D.E., Frangou S., Gallagher P., Jones L., Kieseppa T., Martinez-Aran A., Melle I., Moore P.B., Mur M., Pfennig A., Raust A., Senturk V., Simonsen C., Smith D.J., Bio D.S., Soeiro-de-Souza M.G., Stoddart S.D., Sundet K., Szoke A., Thompson J.M., Torrent C., Zalla T., Craddock N., Andreassen O.A., Leboyer M., Vieta E., Bauer M., Worhunsky P.D., Tzagarakis C., Rogers R.D., Geddes J.R., Goodwin G.M. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatrica Scandinavica 2013, 128(3):149-162.
10. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients[U+05F3] real-world behavior with specific neuropsychological and functional capacity measures. Biological Psychiatry 2008, 63(5):505-511.
11. Brown A.S. The environment and susceptibility to schizophrenia. Progress in Neurobiology 2011, 93(1):23-58.
12. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews Neuroscience 2006, 7(7):583-590.
13. Cuesta M.J., Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Research 1995, 58(3):227-235.
14. Cuesta M.J., Peralta V., Zarzuela A. Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis. Schizophrenia Research 2007, 95(1-3):39-47.
15. Demjaha A., MacCabe J.H., Murray R.M. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophrenia Bulletin 2012, 38(2):209-214.
16. Endicott J., Andreasen N.C., Spitzer R.L. Family history-research diagnostic criteria (FH-RDC) 1978, New York State Psychiatric Institute, New York.
17. Fowler T., Zammit S., Owen M.J., Rasmussen F. A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Archives of General Psychiatry 2012, 69(5):460-466.
18. Gale C.R., Batty G.D., McIntosh A.M., Porteous D.J., Deary I.J., Rasmussen F. Is bipolar disorder more common in highly intelligent people? A cohort study of a million men. Molecular Psychiatry 2013, 18(2):190-194.
19. Glahn D.C., Almasy L., Barguil M., Hare E., Peralta J.M., Kent J.W., Dassori A., Contreras J., Pacheco A., Lanzagorta N., Nicolini H., Raventos H., Escamilla M.A. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Archives of General Psychiatry 2010, 67(2):168-177.
20. Goldberg X., Fatjo-Vilas M., Munoz M.J., Campanera S., Miret S., Minano M.J., Aguilera M., Miralles M.L., Navarro M.E., Lazaro L., Guitart M., Barrantes-Vidal N., Fananas L. Increased familiarity of intellectual deficits in early-onset schizophrenia spectrum disorders. World Journal of Biological Psychiatry 2012, 13(7):493-500.
21. Golden C.J. Stroop color and word test. A manual for clinical and experimental uses 1978, Stoelting Co., Wood Dale, Illinois.
22. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., Kanes S., Blangero J., Gur R.C. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. American Journal of Psychiatry 2007, 164(5):813-819.
23. Heaton R., Chelune G., Talley J., Kay G., Curtiss G. Wisconsin Card Sorting Test 1993, Psychological Assessment Resources, Odessa, FL.
24. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues in Clinical Neurosciences 2010, 12(3):271-287.
25. Kendler K.S., Neale M.C. "Familiality" or heritability. Archives of General Psychiatry 2009, 66(4):452-453.
26. Landmark J. A manual for the assessment of schizophrenia. Acta Psychiatrica Scandinavica 1982, Supplementum 298:1-88.
27. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry 1982, 39(8):879-883.
28. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
29. McGrath J.A., Avramopoulos D., Lasseter V.K., Wolyniec P.S., Fallin M.D., Liang K.Y., Nestadt G., Thornquist M.H., Luke J.R., Chen P.L., Valle D., Pulver A.E. Familiality of novel factorial dimensions of schizophrenia. Archives of General Psychiatry 2009, 66(6):591-600.
30. Murray R.M., Lewis S.W., Reveley A.M. Towards an aetiological classification of schizophrenia. Lancet 1985, 1(8436):1023-1026.
31. Nicodemus K.K., Marenco S., Batten A.J., Vakkalanka R., Egan M.F., Straub R.E., Weinberger D.R. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Molecular Psychiatry 2008, 13(9):873-877.
32. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
33. Owens S.F., Picchioni M.M., Ettinger U., McDonald C., Walshe M., Schmechtig A., Murray R.M., Rijsdijk F., Toulopoulou T. Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain 2012, 135(Pt 7):2231-2244.
34. Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence?. Nature Reviews Neuroscience 2008, 9(12):947-957.
35. Peña-Casanova J. Test Barcelona 1990, Masson, Barcelona.
36. Perala J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsa E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppa T., Harkanen T., Koskinen S., Lonnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 2007, 64(1):19-28.
37. Peralta V., Cuesta M.J. The underlying structure of diagnostic systems of schizophrenia: a comprehensive polydiagnostic approach. Schizophrenia Research 2005, 79(2-3):217-229.
38. Peralta V., Cuesta M.J. The relationship between syndromes of the psychotic illness and familial liability to schizophrenia and major mood disorders. Schizophrenia Research 2007, 91(1-3):200-209.
39. Plomin R., Daniels D. Why are children in the same family so different from one another?. International Journal of Epidemiology 2011, 40(3):563-582.
40. Reitan R., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation 1993, Neuropsychology Press, Tucson, AZ.
41. Reveley A.M., Reveley M.A., Murray R.M. Hypothesis for the etiology of schizophrenia: a genetic perspective. Psychopharmacology Bulletin 1984, 20(3):505-508.
42. Roy M.A., Flaum M.A., Gupta S., Jaramillo L., Andreasen N.C. Epidemiological and clinical correlates of familial and sporadic schizophrenia. Acta Psychiatrica Scandinavica 1994, 89(5):324-328.
43. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophrenia Bulletin 2009, 35(6):1045-1056.
44. Sautter F.J., McDermott B.E., Cornwell J., Wilson A.F., Johnson J., Vasterling J.J. Neuropsychological deficits in probands from multiply-affected schizophrenic families. Journal of Psychiatric Research 1997, 31(5):497-508.
45. Sautter F.J., McDermott B.E., Cornwell J.M., Borges A., Johnson J., Vasterling J.J., Marcontell D.K. A comparison of neuropsychological deficits in familial schizophrenics, nonfamilial schizophrenics, and normal controls. The Journal of Nervous and Mental Disease 1997, 185(10):641-644.
46. Sitskoorn M.M., Aleman A., Ebisch S.J., Appels M.C., Kahn R.S. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophrenia Research 2004, 71(2-3):285-295.
47. Suvisaari J.M., Haukka J., Tanskanen A., Lonnqvist J.K. Age at onset and outcome in schizophrenia are related to the degree of familial loading. British Journal of Psychiatry 1998, 173:494-500.
48. Tenesa A., Haley C.S. The heritability of human disease: estimation, uses and abuses. Nature Reviews Genetics 2013, 14(2):139-149.
49. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468(7321):203-212.
50. Van Os J., Marcelis M., Sham P., Jones P., Gilvarry K., Murray R. Psychopathological syndromes and familial morbid risk of psychosis. British Journal of Psychiatry 1997, 170:241-246.
51. Verdoux H., van Os J., Sham P., Jones P., Gilvarry K., Murray R. Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. British Journal of Psychiatry 1996, 168(5):620-626.
52. Wechsler D. The Wechsler Adult Intelligence Scale Revised (WAIS-R) 1981, The Psychological Corporation, San Antonio, TX.
53. Weissman M.M., Wickramaratne P., Adams P., Wolk S., Verdeli H., Olfson M. Brief screening for family psychiatric history: the family history screen. Archives of General Psychiatry 2000, 57(7):675-682.
54. Welham J., Isohanni M., Jones P., McGrath J. The antecedents of schizophrenia: a review of birth cohort studies. Schizophrenia Bulletin 2009, 35(3):603-623.
55. Wolitzky R., Goudsmit N., Goetz R.R., Printz D., Gil R., Harkavy-Friedman J., Malaspina D. Etiological heterogeneity and intelligence test scores in patients with schizophrenia. Journal of Clinical and Experimental Neuropsychology 2006, 28(2):167-177.
56. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64(6):663-667.
57. Wray N.R., Gottesman I. Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Frontiers Genetics 2012, 3:118.
58. Yoon P.W., Scheuner M.T., Khoury M.J. Research priorities for evaluating family history in the prevention of common chronic diseases. American Journal of Preventive Medicine 2003, 24(2):128-135.